Literature DB >> 21986099

Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device.

Tomoko S Kato1, P Christian Schulze, Jonathan Yang, Ernest Chan, Khurram Shahzad, Hiroo Takayama, Nir Uriel, Ulrich Jorde, Maryjane Farr, Yoshifumi Naka, Donna Mancini.   

Abstract

BACKGROUND: Neurologic complications (NCs) are the major adverse events after left ventricular assist device (LVAD) surgery. Pre-operative and post-operative factors associated with NCs in patients with LVADs were investigated.
METHODS: We reviewed 307 consecutive patients undergoing LVAD surgery (167 HeartMate I and 140 HeartMate II devices) at Columbia University Medical Center between November 2000 and December 2010. Clinical characteristics and hemodynamic and laboratory indexes were analyzed. NC was defined according to the Interagency Registry for Mechanically Assisted Circulatory Support definition of neurologic dysfunction, including transient ischemic attack (TIA) and ischemic or hemorrhagic cerebrovascular accident (CVA).
RESULTS: NCs developed in 43 patients (14.0%) at 91.8 ± 116.3 days post-operatively. The frequency of NC development was similar in HeartMate I and II patients. Patients with NC showed a higher frequency of pre-LVAD CVA history (27.9% vs 15.5%, p = 0.046), lower pre-operative sodium (129.0 ± 7.0 vs 132.1 ± 8.1 mg/dl, p = 0.018) and albumin concentrations (3.5 ± 0.7 vs 3.7 ± 0.6 mg/dl, p = 0.049), lower post-operative hematocrit (34.9% ± 5.1% vs 37.8% ± 6.1%, p = 0.0034), sodium (131.6 ± 7.7 vs 134.4 ± 6.4 mg/dl, p = 0.010) and albumin concentrations (3.7 ± 0.5 vs 3.9 ± 0.5 mg/dl, p = 0.0016), and higher frequency of post-operative infection (39.5% vs 19.3%, p = 0.003) than those without NC. Multiple regression analysis revealed that CVA history (odds ratio, 2.37, 95% confidence interval, 1.24-5.29; p = 0.011) and post-operative infection (odds ratio, 2.99, 95% confidence interval, 1.16-10.49; p = 0.011) were highly associated with NC development. The combination of CVA history, pre-operative and post-operative sodium and albumin, and post-operative hematocrit and infection could discriminate patients developing NCs with a probability of 76.6%.
CONCLUSIONS: Previous stroke, persistent malnutrition and inflammation, severity of heart failure, and post-LVAD infections are key factors associated with development of NCs after LVAD implantation.
Copyright © 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21986099      PMCID: PMC4945759          DOI: 10.1016/j.healun.2011.08.014

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  24 in total

1.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010.

Authors:  Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Paul Aurora; Jason D Christie; Richard Kirk; Fabienne Dobbels; Axel O Rahmel; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2010-10       Impact factor: 10.247

2.  Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

Authors:  Ranjit John; Forum Kamdar; Kenneth Liao; Monica Colvin-Adams; Andrew Boyle; Lyle Joyce
Journal:  Ann Thorac Surg       Date:  2008-10       Impact factor: 4.330

3.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

Authors:  Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Journal:  Eur Heart J       Date:  2007-02-19       Impact factor: 29.983

4.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2010-01       Impact factor: 10.247

5.  Left ventricular assist device and drug therapy for the reversal of heart failure.

Authors:  Emma J Birks; Patrick D Tansley; James Hardy; Robert S George; Christopher T Bowles; Margaret Burke; Nicholas R Banner; Asghar Khaghani; Magdi H Yacoub
Journal:  N Engl J Med       Date:  2006-11-02       Impact factor: 91.245

Review 6.  The role of bridge to transplantation: should LVAD patients be transplanted?

Authors:  Emma J Birks; Magdi H Yacoub; Nicholas R Banner; Asghar Khaghani
Journal:  Curr Opin Cardiol       Date:  2004-03       Impact factor: 2.161

7.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

8.  Cerebrovascular accidents in patients with a ventricular assist device.

Authors:  Hiroyuki Tsukui; Adib Abla; Jeffrey J Teuteberg; Dennis M McNamara; Michael A Mathier; Linda M Cadaret; Robert L Kormos
Journal:  J Thorac Cardiovasc Surg       Date:  2007-06-04       Impact factor: 5.209

9.  Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.

Authors:  Ana C Alba; Vivek Rao; Joan Ivanov; Heather J Ross; Diego H Delgado
Journal:  J Heart Lung Transplant       Date:  2009-08       Impact factor: 10.247

Review 10.  Infection as a risk factor for cerebral infarction.

Authors:  J Syrjänen
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

View more
  26 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.

Authors:  Hiroo Takayama; Lori Soni; Bindu Kalesan; Lauren K Truby; Takeyoshi Ota; Sophia Cedola; Zain Khalpey; Nir Uriel; Paolo Colombo; Donna M Mancini; Ulrich P Jorde; Yoshifumi Naka
Journal:  Circ Heart Fail       Date:  2014-07-15       Impact factor: 8.790

3.  Permanent Implantable Cardiac Support Systems.

Authors:  Jan F Gummert; Axel Haverich; Jan D Schmitto; Evgenij Potapov; René Schramm; Volkmar Falk
Journal:  Dtsch Arztebl Int       Date:  2019-12-13       Impact factor: 5.594

Review 4.  Hypertension and Stroke in Patients with Left Ventricular Assist Devices (LVADs).

Authors:  Joshua Z Willey; Amelia K Boehme; Francesco Castagna; Melana Yuzefpolskaya; A Reshad Garan; Veli Topkara; Paolo C Colombo
Journal:  Curr Hypertens Rep       Date:  2016-02       Impact factor: 5.369

5.  Clinical results with Jarvik 2000 axial flow left ventricular assist device: Osaka University Experience.

Authors:  Daisuke Yoshioka; Goro Matsumiya; Koichi Toda; Taichi Sakaguchi; Yasushi Yoshikawa; Shunsuke Saito; Hikaru Matsuda; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2014-07-22       Impact factor: 1.731

6.  Mechanical circulatory support devices as destination therapy-current evidence.

Authors:  Thomas Puehler; Stephan Ensminger; Michael Schoenbrodt; Jochen Börgermann; Erik Rehn; Kavous Hakim-Meibodi; Michiel Morshuis; Jan Gummert
Journal:  Ann Cardiothorac Surg       Date:  2014-09

Review 7.  Blood stream infection is associated with cerebrovascular accident in patients with left ventricular assist device: a systematic review and meta-analysis.

Authors:  Napatt Kanjanahattakij; Benjamin Horn; Basma Abdulhadi; Nicha Wongjarupong; Kenechukwu Mezue; Pattara Rattanawong
Journal:  J Artif Organs       Date:  2018-03-16       Impact factor: 1.731

Review 8.  [The chronic critically ill patient from the cardiologist's perspective].

Authors:  U Janssens; S Reith
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-04-25       Impact factor: 0.840

9.  Stroke Risk and Mortality in Patients With Ventricular Assist Devices.

Authors:  Neal S Parikh; Joséphine Cool; Maria G Karas; Amelia K Boehme; Hooman Kamel
Journal:  Stroke       Date:  2016-09-20       Impact factor: 7.914

Review 10.  Neurologic Complications in the Intensive Care Unit.

Authors:  Clio Rubinos; Sean Ruland
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.